A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges
King, Allen B, Philis-Tsimikas, Athena, Kilpatrick, Eric S, Langbakke, Irene H, Begtrup, Kamilla, Vilsbøll, Tina
Published in Diabetes technology & therapeutics (01.04.2017)
Published in Diabetes technology & therapeutics (01.04.2017)
Get more information
Journal Article
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile
Levy, Jerrold H., Fingerhut, Abe, Brott, Thomas, Langbakke, Irene H., Erhardtsen, Elisabeth, Porte, Robert J.
Published in Transfusion (Philadelphia, Pa.) (01.06.2006)
Published in Transfusion (Philadelphia, Pa.) (01.06.2006)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics of growth hormone in patients on chronic haemodialysis compared with matched healthy subjects: an open, nonrandomized, parallel-group trial
Langbakke, Irene H., Nielsen, Jakob N., Skettrup, Mia P., Harper, Angela, Klitgaard, Thomas, Weil, Angelika, Engelhardt, Eva, Lange, Martin
Published in Clinical endocrinology (Oxford) (01.11.2007)
Published in Clinical endocrinology (Oxford) (01.11.2007)
Get full text
Journal Article
140 - Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine
Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine
Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
CA-190 - Les diabétiques de type 2 traités par insuline degludec/liraglitude (IDegLira) ont plus de chances d’atteindre les objectifs glycémiques sans hypoglycémies ni prise de poids qu’avec l’insuline Glargine U100 (IGlar U100)
Sérusclat, Pierre, Belhatem, Narimène, Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Pérez Manghi, Federico C.
Published in Diabetes & metabolism (01.03.2017)
Published in Diabetes & metabolism (01.03.2017)
Get full text
Journal Article
Les diabétiques de type 2 traités par insuline degludec/liraglitude (IDegLira) ont plus de chances d’atteindre les objectifs glycémiques sans hypoglycémies ni prise de poids qu’avec l’insuline Glargine U100 (IGlar U100)
Sérusclat, Pierre, Belhatem, Narimène, Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Pérez Manghi, Federico C.
Published in Diabetes & metabolism (01.03.2017)
Published in Diabetes & metabolism (01.03.2017)
Get full text
Journal Article